A continuum hypothesis of psychotomimetic rapid antidepressants
The paper proposes a continuum hypothesis that psychotomimetic rapid antidepressants (ketamine, classical psychedelics and sleep deprivation) produce acute antidepressant effects by increasing the flexibility of prior expectations within a hierarchical predictive coding framework, thereby linking their antidepressant and psychotomimetic actions. It reviews supporting neurobiological and neuromodulatory evidence, contrasts the idea with other antidepressant theories, and proposes experiments to test the hypothesis.
Authors
- Haarsma, J.
- Harmer, C. J.
- Tamm, S.
Published
Abstract
Ketamine, classical psychedelics and sleep deprivation are associated with rapid effects on depression. Interestingly, these interventions also have common psychotomimetic actions, mirroring aspects of psychosis such as an altered sense of self, perceptual distortions and distorted thinking. This raises the question whether these interventions might be acute antidepressants through the same mechanisms that underlie some of their psychotomimetic effects. That is, perhaps some symptoms of depression can be understood as occupying the opposite end of a spectrum where elements of psychosis can be found on the other side. This review aims at reviewing the evidence underlying a proposed continuum hypothesis of psychotomimetic rapid antidepressants, suggesting that a range of psychotomimetic interventions are also acute antidepressants as well as trying to explain these common features in a hierarchical predictive coding framework, where we hypothesise that these interventions share a common mechanism by increasing the flexibility of prior expectations. Neurobiological mechanisms at play and the role of different neuromodulatory systems affected by these interventions and their role in controlling the precision of prior expectations and new sensory evidence will be reviewed. The proposed hypothesis will also be discussed in relation to other existing theories of antidepressants. We also suggest a number of novel experiments to test the hypothesis and highlight research areas that could provide further insights, in the hope to better understand the acute antidepressant properties of these interventions.
Research Summary of 'A continuum hypothesis of psychotomimetic rapid antidepressants'
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Compound
- Topics
- APA Citation
Haarsma, J., Harmer, C. J., & Tamm, S. (2021). A continuum hypothesis of psychotomimetic rapid antidepressants. Brain and Neuroscience Advances, 5. https://doi.org/10.1177/23982128211007772
References (25)
Papers cited by this study that are also in Blossom
Basso, L., Bönke, L., Aust, S. et al. · Journal of Psychiatric Research (2020)
Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)
Bobo, W. V., Vande Voort, J. L., Croarkin, P. E. et al. · Depression and Anxiety (2016)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Roseman, L., Bolstridge, M. et al. · Scientific Reports (2017)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Carter, O. L., Hasler, F. ;., Pettigrew, J. D. et al. · Psychopharmacology (2007)
Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)
Heuschkel, K., Kuypers, K. P. C. · Frontiers in Psychiatry (2020)
Kanen, J. W., Luo, Q., Kandroodi, M. R. et al. · Psychological Medicine (2020)
Show all 25 referencesShow fewer
Kishimoto, T., Chawla, J. M., Hagi, K. et al. · Psychological Medicine (2016)
Kometer, M., Cahn, B. R., Andel, D. et al. · Biological Psychiatry (2011)
Lally, N., Nugent, A. C., Luckenbaugh, D. A. et al. · Translational Psychiatry (2014)
Nutt, D. J. · Journal of Psychopharmacology (2015)
Leptourgos, P., Fortier-Davy, M., Carhart-Harris, R. L. et al. · Schizophrenia Bulletin (2020)
Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)
Newport, D. J., Carpenter, L. L., Mcdonald, W. M. et al. · American Journal of Psychiatry (2015)
Nugent, A. C., Ballard, E. D., Gould, T. D. et al. · Molecular Psychiatry (2018)
Quednow, B. B., Kometer, M., Geyer, M. A. et al. · Neuropsychopharmacology (2011)
Reiff, C. M., Richman, E. E., Nemeroff, C. B. et al. · American Journal of Psychiatry (2020)
Roseman, L., Demetriou, L., Wall, M. B. et al. · Neuropharmacology (2018)
Schmid, Y., Enzler, F., Gasser, P. et al. · Biological Psychiatry (2015)
Sos, P., Klirova, M., Novák, T. et al. · Neuropsychiatric Disease And Treatment (2013)
Timmermann, C., Spriggs, M. J., Kaelen, M. et al. · Neuropharmacology (2018)
Vollenweider, F. X., Kometer, M. · Nature Reviews Neuroscience (2010)
Cited By (3)
Papers in Blossom that reference this study
Martens, M. A. G., Cunha, B. G., Erritzoe, D. et al. · Translational Psychiatry (2025)
Sadibolova, R., Murray-Lawson, C., Family, N. et al. · Biorxiv (2023)
Mathai, D. S., Nayak, S., Yaden, D. B. et al. · Psychopharmacology (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.